🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Altimmune, Inc.

ALT Healthcare
$1.33 $-0.08 (-5.67%)
Market Cap: $258.8 M
Gurus Holding
5
Popularity Rank
#1810
% of Shares Held
4.30%
Net Activity (Q3 2026)
-$898,008.93

Guru Ownership Trend

Guru Analysis for Altimmune, Inc. (ALT)

Altimmune, Inc. (ALT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $11.13 M.

Top institutional holders include Andreas Halvorsen and Steven Cohen.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $898,008.93 net outflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 199.6%. Conversely, Cliff Asness reduced exposure by 94.8%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q3 2026)

+$2.88 M
Total Buy Value
New Buys 0
Additions 2
-$3.78 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Altimmune, Inc. (ALT)

Major holders include Andreas Halvorsen ($19.16 M), Steven Cohen ($4.17 M), Renaissance Technologies (RenTech) ($309,298). According to the latest reported data, 5 tracked investment managers collectively hold approximately 8.37 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $898,008.93, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ALT. The total reported sell value was $3.78 M.

Yes, 0 managers opened new positions in ALT, and 2 increased their existing holdings. The total reported buy value was $2.88 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.06% 6,700,000 $19.16 M Q3 2026
0.00% Add 199.6% 1,458,907 $4.17 M Q3 2026
0.00% Add 51.0% 108,146 $309,298 Q3 2026
0.00% Reduce -94.8% 63,485 $181,566 Q3 2026
0.00% Reduce -57.5% 35,659 $101,985 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form